rs7241380

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378183.1(PIEZO2):​c.3081C>T​(p.Leu1027Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.791 in 1,536,988 control chromosomes in the GnomAD database, including 481,780 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 46624 hom., cov: 35)
Exomes 𝑓: 0.79 ( 435156 hom. )

Consequence

PIEZO2
NM_001378183.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.286

Publications

17 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 18-10762964-G-A is Benign according to our data. Variant chr18-10762964-G-A is described in ClinVar as Benign. ClinVar VariationId is 261505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.286 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.86 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO2NM_001378183.1 linkc.3081C>T p.Leu1027Leu synonymous_variant Exon 22 of 56 ENST00000674853.1 NP_001365112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO2ENST00000674853.1 linkc.3081C>T p.Leu1027Leu synonymous_variant Exon 22 of 56 NM_001378183.1 ENSP00000501957.1 A0A2H4UKA7

Frequencies

GnomAD3 genomes
AF:
0.782
AC:
118939
AN:
152098
Hom.:
46596
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.777
Gnomad AMI
AF:
0.710
Gnomad AMR
AF:
0.728
Gnomad ASJ
AF:
0.846
Gnomad EAS
AF:
0.881
Gnomad SAS
AF:
0.759
Gnomad FIN
AF:
0.788
Gnomad MID
AF:
0.829
Gnomad NFE
AF:
0.788
Gnomad OTH
AF:
0.782
GnomAD2 exomes
AF:
0.775
AC:
111788
AN:
144308
AF XY:
0.777
show subpopulations
Gnomad AFR exome
AF:
0.783
Gnomad AMR exome
AF:
0.671
Gnomad ASJ exome
AF:
0.840
Gnomad EAS exome
AF:
0.881
Gnomad FIN exome
AF:
0.775
Gnomad NFE exome
AF:
0.794
Gnomad OTH exome
AF:
0.788
GnomAD4 exome
AF:
0.792
AC:
1096951
AN:
1384772
Hom.:
435156
Cov.:
60
AF XY:
0.791
AC XY:
540664
AN XY:
683318
show subpopulations
African (AFR)
AF:
0.776
AC:
24500
AN:
31586
American (AMR)
AF:
0.680
AC:
24269
AN:
35694
Ashkenazi Jewish (ASJ)
AF:
0.838
AC:
21097
AN:
25182
East Asian (EAS)
AF:
0.880
AC:
31434
AN:
35730
South Asian (SAS)
AF:
0.761
AC:
60310
AN:
79214
European-Finnish (FIN)
AF:
0.775
AC:
27138
AN:
35000
Middle Eastern (MID)
AF:
0.823
AC:
4685
AN:
5694
European-Non Finnish (NFE)
AF:
0.795
AC:
857255
AN:
1078762
Other (OTH)
AF:
0.799
AC:
46263
AN:
57910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
12888
25776
38663
51551
64439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20404
40808
61212
81616
102020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.782
AC:
119013
AN:
152216
Hom.:
46624
Cov.:
35
AF XY:
0.782
AC XY:
58207
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.776
AC:
32231
AN:
41530
American (AMR)
AF:
0.728
AC:
11140
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.846
AC:
2939
AN:
3472
East Asian (EAS)
AF:
0.881
AC:
4557
AN:
5172
South Asian (SAS)
AF:
0.760
AC:
3671
AN:
4828
European-Finnish (FIN)
AF:
0.788
AC:
8340
AN:
10580
Middle Eastern (MID)
AF:
0.833
AC:
245
AN:
294
European-Non Finnish (NFE)
AF:
0.788
AC:
53585
AN:
68016
Other (OTH)
AF:
0.785
AC:
1659
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1356
2713
4069
5426
6782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.781
Hom.:
16779
Bravo
AF:
0.780
Asia WGS
AF:
0.846
AC:
2942
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gordon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Marden-Walker syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis, distal, with impaired proprioception and touch Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
5.6
DANN
Benign
0.71
PhyloP100
-0.29
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7241380; hg19: chr18-10762962; COSMIC: COSV108125171; COSMIC: COSV108125171; API